Form 8-K

Trius Therapeutics, Inc.

Dated: June 3, 2011

/s/ John P. Schmid

John P. Schmid

Chief Financial Officer

0001193125-11-158185.txt : 20110603 0001193125-11-158185.hdr.sgml : 20110603 20110603132110 ACCESSION NUMBER: 0001193125-11-158185 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110602 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20110603 DATE AS OF CHANGE: 20110603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trius Therapeutics Inc CENTRAL INDEX KEY: 0001356857 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201320630 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34828 FILM NUMBER: 11891297 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-452-0370 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 8-K 1 d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): June 2, 2011

TRIUS THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)


Delaware	001-34828	20-1320630
(State of incorporation or organization)	(Commission file number)	(I.R.S. Employer Identification Number)

6310 Nancy Ridge Drive, Suite 101 San Diego, CA		92121
(Address of principal executive offices)		(Zip code)

Registrant’s telephone number, including area code: (858) 452-0370

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.07.

Submission of Matters to a Vote of Security Holders.

Our 2011 Annual Meeting of Stockholders was held on June 2, 2011. We had 23,667,333 shares of common stock outstanding and entitled to vote as of April 12, 2011, the record date for the Annual Meeting. At the Annual Meeting, 18,965,057 shares of common stock were present in person or represented by proxy for the two proposals specified below.

At the Annual Meeting, stockholders:

(1) elected Brian G. Atwood, David S. Kabakoff, Ph.D., Nina Kjellson and Brendan O’Leary, Ph.D. as Class I directors to hold office until the 2014 Annual Meeting of Stockholders; and

(2) ratified the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2011.

The following sets forth detailed information regarding the final results of the voting for the Annual Meeting:

Proposal 1. Election of Directors


Name	Votes For	Votes Withheld	Broker Non-Votes

Brian G. Atwood	17,052,016	2,218	1,910,823
David S. Kabakoff, Ph.D.	17,052,016	2,218	1,910,823
Nina Kjellson	17,050,334	3,900	1,910,823
Brendan O’Leary, Ph.D.	17,050,534	3,700	1,910,823

Proposal 2. Ratification of the selection of Independent Registered Public Accounting Firm


Votes For	Votes Against	Abstentions	Broker Non-Votes
18,954,327	8,061	2,669	—

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.